Document Detail

Drilling speaking valves to promote phonation in tracheostomy-dependent children.
MedLine Citation:
PMID:  22777746     Owner:  NLM     Status:  Publisher    
OBJECTIVES/HYPOTHESIS: Placement of a Passy-Muir speaking valve is considered best practice for infants and children with a tracheostomy. The Passy-Muir valve enables phonation by redirecting exhaled air via the glottis. Poor tolerance of the Passy-Muir valve is associated with excessive transtracheal pressures on exhalation due to upper airway obstruction. Drilling a small hole in the side of the Passy-Muir valve creates a pressure relief port to allow partial exhalation through the tracheostomy tube while enabling phonation. STUDY DESIGN: A retrospective case series is presented of 10 aphonic pediatric patients with a tracheostomy trialed with a drilled Passy-Muir valve. METHODS: Valve tolerance was assessed clinically and objectively. Handheld manometry was used to determine transtracheal pressures on passive exhalation. All patients had a diagnosis of upper airway obstruction and demonstrated excessive pressures wearing a standard Passy-Muir valve. Patients were assessed wearing a Passy-Muir valve with up to two 1.6-mm holes drilled in the side of the valve. Patients progressed to trials if clinically stable and if transtracheal pressure did not exceed 10 cm H(2) O when wearing the valve. RESULTS: Eight patients progressed to trial, with five of eight patients able to phonate within 1 week and six of eight able to tolerate wearing the valve for ≥2-hour periods within 2 weeks of introduction. All eight patients were able to phonate within 6 months of valve introduction. CONCLUSIONS: These findings support drilling Passy-Muir speaking valves as a promising option to facilitate phonation in pediatric patients with a tracheostomy for upper airway obstruction. Laryngoscope, 2012.
Alison Buckland; Lara Jackson; Toni Ilich; Jodi Lipscombe; Graeme Jones; Shyan Vijayasekaran
Related Documents :
2171046 - Heart rate response to peptide histidine valine in human subjects is not mediated throu...
15314476 - Beta-adrenoceptor blockers as agonists: coupling of beta2-adrenoceptors to multiple g-p...
18680946 - Hydrolysis under high hydrostatic pressure as a means to reduce the binding of beta-lac...
66056 - Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its...
2296496 - Different high-frequency ventilator strategies: effect on the propagation of tracheobro...
10896816 - Pulmonary vascular pressures increase after lung volume reduction surgery in rabbits wi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-9
Journal Detail:
Title:  The Laryngoscope     Volume:  -     ISSN:  1531-4995     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8607378     Medline TA:  Laryngoscope     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.
Department of Speech Pathology, Princess Margaret Hospital, Perth, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Interactive toxicity of usnic acid and lipopolysaccharides in human liver HepG2 cells.
Next Document:  Macromolecule-suppressed GABA-edited magnetic resonance spectroscopy at 3T.